Vaxart, Inc. VXRT
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 29.04M | 38.59M | 37.10M | 16.33M | -50.70M |
| Total Depreciation and Amortization | 5.19M | 6.00M | 7.46M | 8.58M | 8.76M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.59M | 7.45M | 6.67M | 5.37M | 7.10M |
| Change in Net Operating Assets | -8.00M | -18.06M | -35.96M | -22.56M | 4.55M |
| Cash from Operations | 32.82M | 33.98M | 15.26M | 7.71M | -30.29M |
| Capital Expenditure | -855.00K | -601.00K | -463.00K | -145.00K | -188.00K |
| Sale of Property, Plant, and Equipment | 14.00K | 18.00K | 8.00K | 5.00K | 5.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -18.22M | -6.64M | 3.18M | 16.77M | 25.23M |
| Cash from Investing | -19.06M | -7.23M | 2.72M | 16.63M | 25.05M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.22M | 4.80M | 4.62M | 4.62M | 3.04M |
| Repurchase of Common Stock | -389.00K | -389.00K | -370.00K | -199.00K | -184.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -356.00K | -351.00K | -184.00K | -184.00K | -2.76M |
| Cash from Financing | 4.48M | 4.06M | 4.07M | 4.24M | 93.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.24M | 30.82M | 22.05M | 28.59M | -5.16M |